Clinical Trials
- Brain and Other Nervous System Cancers, Pediatric Cancers
A Target Validation/Phase1 Study of BGB-290 in Combination With Temozolomide in Adolescent and Young Adult IDH1/2 Newly Diagnosed and Recurrent Mutant Gliomas
- Date09/25/2020
- Brain and Other Nervous System Cancers
A Phase 3 Randomized Non-Inferiority Study of Carboplatin and Vincristine Versus Selumetinib (NSC# 748727) in Newly Diagnosed or Previously Untreated Low-Grade Glioma (LGG) Not Associated With BRAFV600E Mutations or Systemic Neurofibromatosis Type 1 (NF1)
- Date02/24/2022
- Brain, Spinal Cord & Nervous System
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis (ExTINGUISH)
- Ages18 years and older
- GenderBoth
- Date05/06/2022
- Child Development & Autism, Children's Health
Understanding regulation of visual attention and emotion in autism
- Ages4 months - 8 years
- GenderBoth
- Date09/15/2008
- Children's Health, Mental Health & Behavioral Research
Pilot Study of Parent Training for Pediatric Avoidant/Restrictive Food Intake Disorder
- Ages6 years - 18 years
- GenderBoth
- Date02/02/2018
- Brain, Spinal Cord & Nervous System, Alzheimer's
Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
- Ages50 years - 90 years
- GenderBoth
- Date01/04/2019
- Men's Health, Women's Health
Evaluating the Safety, Tolerability, Pharmacokinetics and Receptor Occupancy of BMS-984923
- Ages50 years - 80 years
- GenderBoth
- Date03/25/2021
- Brain and Other Nervous System Cancers
A Phase 1 Trial to Evaluate the Safety and Tolerability of Fb-PMT in Patients With Recurrent Glioblastoma
- Date05/05/2022
- Children's Health, Headaches
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS1)
- Ages6 years - 17 years
- GenderBoth
- Date03/02/2021
- Brain, Spinal Cord & Nervous System
Myasthenia Gravis Inebilizumab Trial (MINT)
- Ages18 years and older
- GenderBoth
- Date04/01/2021